v3.26.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 20,700 $ 17,888
Premium and trade receivables 20,329 18,105
Short-term investments 2,886 2,432
Other current assets 1,546 1,945
Total current assets 45,461 40,370
Long-term investments 14,794 17,035
Restricted deposits 1,470 1,412
Property, software and equipment, net 2,109 2,037
Goodwill 10,835 10,835
Intangible assets, net 4,042 4,530
Other long-term assets 569 528
Total assets 79,280 76,747
Current liabilities:    
Medical claims liability 21,495 20,544
Accounts payable and accrued expenses 15,459 13,796
Return of premium payable 1,346 1,592
Unearned revenue 680 736
Current portion of long-term debt 88 50
Total current liabilities 39,068 36,718
Long-term debt 15,454 17,351
Deferred tax liability 719 833
Other long-term liabilities 1,732 1,789
Total liabilities 56,973 56,691
Commitments and contingencies
Redeemable noncontrolling interests 24 23
Stockholders' equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 626,679 issued and 494,973 outstanding at September 30, 2026, and 623,463 issued and 491,757 outstanding at December 31, 2025 1 1
Additional paid-in capital 20,926 20,777
Accumulated other comprehensive (loss) (514) (58)
Retained earnings 11,235 8,674
Treasury stock, at cost (131,706 and 131,706 shares, respectively) (9,441) (9,441)
Total Centene stockholders' equity 22,207 19,953
Nonredeemable noncontrolling interest 76 80
Total stockholders' equity 22,283 20,033
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 79,280 $ 76,747